Our strategy is to leverage our Drug Discovery Platform to develop new Drug Candidates for the treatment of cancer and other serious medical conditions.
Conduct all screening and pre-clinical research at our in-house state of the art laboratory facilities
Expand and protect the technology, inventions, and trade secrets that are critical for our business
Leverage proprietary bioinformatics platform to develop novel cannabinoid formulations & research programs
Follow FDA targeted Regulatory Affairs strategy & clinical development programs
CNBX’s revolutionary lab uses a bioinformatics platform for rapid evaluation of the therapeutic effects of thousands of compounds against a growing library of cancer cell lines and biopsies. Features of the platform include:
High-throughput and highcontent screening (HTS)
Custom matrix of cancer cell lines and cannabinoid compounds
Database of biological
response data
Fully integrated research and development operation
In-vivo studies
& experiments
Regulatory Affairs
expertise